万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://onlinelibrary.wiley.com/journal/20426984
3、投稿网址：http://mc.manuscriptcentral.com/alr
4、官网邮箱：IFAR@wiley.com（编辑部）
5、期刊刊期：月刊，一年出版12期。
2021年7月20日星期二
投稿须知【官网信息】
Author Guidelines
About International Forum of Allergy & Rhinology (IFAR)
International Forum of Allergy & Rhinology (IFAR) is a peer-reviewed scientific journal, published by John Wiley & Sons, Inc. The International Forum of Allergy & Rhinology provides a forum for clinicians, clinical researchers, basic scientists, and others to publish original research and explore controversies in the medical and surgical treatment of patients with rhinologic, otolaryngic allergy, and skull base conditions. IFAR is the pre-eminent scholarly journal publishing more articles and receiving more citations than any other journal in this domain. Our editorial goal at IFAR is to identify original manuscripts that will have substantial impact on the field as measured by future citations of the work and/or downloads from the various online sources. We understand that you have many options for publishing your work. At IFAR, we promise to work hard to give you timely, helpful and collegial feedback. If your manuscript is accepted for publication in IFAR, we will work hard to disseminate your work around the globe. Unsolicited manuscripts must meet pre-submission requirements.
Manuscript Types
Quick Reference IFAR Article Portfolio
Research Articles
These reports typically include randomized trials, intervention studies, cohort studies, case-control studies, epidemiologic assessments, other observational studies, surveys with high response rates, cost-effectiveness analyses and decision analyses, translational research and studies of screening and diagnostic tests. Systematic reviews with meta-analysis are included under this category. Research articles are generally 3500 words or fewer, exclusive of tables, figures, and references, and include the following section headings: Introduction, Materials and Methods, Results, Discussion, and Conclusion, which should conform to standard scientific reporting style. The introduction should include a succinct summary of the known literature in the area with a focus on recently published studies, the rationale for and justification of the purpose of the study, and why the experimental question and hypothesis are important or novel for the practicing clinician. Please do not include broad overviews of the topic in the introduction (e.g., “CRS affects 12% of the population and often requires treatment with medical and surgical therapy”), rather, focus on the specific topic at hand and the rationale for the study.
The Methods section should contain clear inclusion and exclusion criteria for study participant selection as well as descriptions of blinding and/or randomization techniques, as applicable. Participant flowcharts are useful tools for describing those study protocols. Reporting of statistical analyses should clearly describe the methods selected for group comparisons based on distribution normality for all bivariate and multivariate testing. Additional reporting will include the name of the statistical test, all associated effect estimates (e.g., means, frequencies, correlation coefficients, etc.), measure of variance including standard deviations and 95% confidence intervals, degrees of freedom, as well as one- or two-tailed indications, as appropriate. P-values will be reported for all comparisons, including non-significant differences, using at least 2 digits after the decimal point (e.g. p=0.03) unless the 2nd digit is also a zero wherein a 3rd digit can be used instead (e.g., p<0.001). The use of only a p-value is not sufficient and should be accompanied by additional measures of data variance. Multivariate testing should include additional descriptions of modeling parameters, including entry and exclusion criteria, as well as techniques to decide goodness-of-fit for final models. Statistical reporting that conveys the clinical significance of the findings is required. Reporting results as a binary “significant” or “non-significant” P value is insufficient. By reporting results in this way, important information regarding how much of a difference was observed and whether study results are potentially clinically significant is lost. Instead, the size of the observed difference, also known as the effect size, and the precision of the estimate, defined by the width of the confidence interval (CI) around that effect size, should be calculated. The combination of the effect size and the 95% CI should then be interpreted to explain whether results are consistent with a clinically meaningful effect.
The Discussion section should include a clear exposition of the clinical and scientific importance of the study. Articles should strive to highlight the clinical meaning of the results. All confidence intervals (CIs) should be interpreted in the discussion of study results. This discussion should center on whether the CI demonstrates that study results are consistent with a clinically meaningful effect and warrant further investigation, or whether the effect is not likely to be clinically meaningful. Conclusions must be clearly justified from the study data. Be aware that over-reaching on conclusions is a common problem seen during peer review.
Videos are encouraged. We allow three videos files no longer than 30 seconds each or one video at one and a half minutes in length. Connected and continually-playing segments are allowed within each video file. In exceptional cases, a longer segment may be considered with prior permission of one of the editors.
Original Research Manuscript Checklist for Authors:
Is a succinct rationale provided in the Introduction?
Is the description of the study design clear and appropriate?
Is the number of subjects enrolled/included and number of subjects per group reported?
Is a clear definition of the primary outcome measure and secondary outcome measure(s), if any, provided?
Was a power calculation performed and sample size determined prior to the conduct of study?
Is a clinically meaningful difference identified and referred to in the interpretation of the results?
Is missing data reported?
Is the complete duration of follow-up time reported?
Are results reported as n (%) for categorical variables?
Are mean (std dev) or median (range) reported for continuous variables?
Is a description of the study population included (Table 1)?
Are p-values present in the manuscript? If so, they need to be reported along with effect size and 95% CIs.
Are variables included in the tables used in the analysis?
Review Articles
Review Articles of various types (e.g., Systematic Reviews without meta-analysis, Narrative Reviews, Evidence Based Reviews) address current topics of specialty importance. These are commonly written or led by a well-recognized leader in the field and can have a variety of lengths and Figures/Tables depending on content and topic. Authors should generally follow the author guidelines for Original Research Manuscripts for length and Table/Figures.
Research Note
Research Notes are peer-reviewed publications of clinical or laboratory observations, in abbreviated form. Research Notes are limited in scope relative to full length Original Research Manuscripts. Citation research shows that Research Notes are peer-reviewed, indexed in Medline, accessible to literature searches, and cited.
Research Note must:
(1) Have a 900 word limit with maximum of 2 tables or figures
(2) Have the following subsections: Introduction, Methods, Results, Discussion
(3) Have a complete title page including author's name(s), academic degree(s), institutions(s), and location(s) with Corresponding Author information
(4) Have no more than 10 references
(5) NOT include an abstract
Viewpoints
Viewpoints convey the opinion of an author or group of authors and inform practice or its related science. While liberty is given to extrapolate beyond the usual confines of a scientific manuscript, opinions must be reasonably fact-based and contain logical inferences. Opinions about clinical practice or scientific data are appropriate where there are barriers to actual prospective testing of an issue. Authors should efficiently convey their message keeping Viewpoints as brief as possible.
Viewpoints must:
Have a complete title page including author's name(s), academic degree(s), institutions(s), and location(s) with Corresponding Author information
NOT include an abstract
Should begin with a Section called Summary which summarizes the opinion and salient points in 200 words or less.
Limited to 2000 words including Summary and main text only
Limited to 3 figures
Clinical Letter
Clinical Letters are brief reports of unique cases, small case series, treatment techniques, or interesting clinical observations.
750 word limit
No Abstract
≤6 references
≤2 small tables and/or figures
Have a complete title page including author's name(s), academic degree(s), institutions(s), and location(s) with Corresponding Author information
Correspondence and Reply
Correspondence concerning recent publications in IFAR or other subjects of unique interest to the readership will be considered for publication and accepted based on their pertinence, their scientific quality, and available space in the Journal. When a particular Journal article is referenced in a Correspondence, Reply from the authors of the article will be requested. If approved through the editorial processes, the Correspondence and relevant Reply will both be published.
Both Correspondence and Reply must:
Contain no more than 750 words
Have a short, relevant title
Have a complete title page
List the references as complete bibliographic citations at the end of the letter and, if applicable, with the journal article being discussed as the first reference
Cite references (where appropriate to the subject), but no more than five
Have no more than one table or figure
Begin with the salutation “To the Editor:” and close with the author's name(s), academic degree(s), institutions(s), and location(s)
Correspondence and Reply Letter authors must observe any licenses or copyrights on original material, are entirely responsible for the accuracy of the content, and must disclose any potential conflicts of interest. Submitting authors are required to provide a valid name and email address, which will be published with their Letter. Letters are acknowledged upon receipt, but Letter authors will not necessarily be consulted before publication. All submitted Letters become property of the American Rhinologic Society and the American Academy of Otolaryngic Allergy, and may be edited by the editorial office for clarity or length.
Editorials
Editorials may address any important topic in medicine, public health, research, discovery, prevention, ethics, health policy, or health law and generally are not linked to a specific article. Editorials should be focused, scholarly, and clearly presented and should not include the findings of new research or data that have not been previously published.
Editorials generally have one author but must have no more than 3 authors. Maximum length is up to 1000 words of text with one small table or figure, and no more than 10 references. Close with the author's name(s), academic degree(s), institutions(s), and location(s) at the end of the Editorial, prior to the references.
Submission Guidelines
Material submitted to International Forum of Allergy & Rhinology must be original and not published or submitted for publication elsewhere. Copies of any related in press publications should accompany manuscripts submitted to International Forum of Allergy & Rhinology.
Online Submission Procedure
International Forum of Allergy & Rhinology uses ScholarOne Manuscripts, a Web-based, peer-review tracking system, for online submission of all manuscripts.
Authors are required to submit the following manuscript information online using ScholarOne Manuscripts:
Corresponding author's contact information (a valid e-mail address is required)
Manuscript title
Abstract
Cover letter
Keywords
Acknowledgements
Additional Files
Appendices
Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.
Supporting Information
Supporting information is information that is not essential to the article, but provides greater depth and background primarily related to methodology. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.
Once a manuscript has been submitted online, an e-mail acknowledgment will be sent. Authors can check the status of a manuscript at any time by logging on to ScholarOne Manuscripts.
Format of Manuscript Elements
Manuscripts must be in English with wide (1 inch) margins, typed and double-spaced throughout. Please number pages consecutively, and include the corresponding author's name on each page using a page header. Manuscripts should contain each of the following sections in sequence: 1) Title page 2) Abstract 3) Text 4) Acknowledgments 5) References 6) Tables 7) Figure/Video legends. Start each section on a new page. Define unusual abbreviations at the first mention in the text.
Manuscripts should follow the AMA Manual of Style (10th ed.) for grammar, punctuation, and style, and should meet the Uniform Requirements for Manuscripts Submitted to Biomedical Journals established by the ICMJE for general authorship guidelines.
Use generic drug names in the text; use of brand names is optional, and these should be specified in parentheses. The text should be written in a uniform style and its contents, as submitted for consideration, should be deemed final by the authors and suitable for publication as follows:
Title Page
The title page should contain the complete title of the manuscript (150 characters or less) names and affiliations of all authors, institution(s) at which the work was performed, and name, address, telephone and fax numbers, and E-mail address of the author responsible for correspondence. Authors should also provide a short, running header title of not more than 50 characters (including spaces), and must identify a minimum of 3 key words (and up to 7 key words), not in the title but taken from Index Medicus, that will highlight the subject matter of the article. Any funding sources for the study (whether financial or in-kind) and any authors’ financial disclosures and conflict of interest should be listed on this page as well as in the cover letter. When authors have no financial disclosures, this should be specifically noted as well.
Here are a few tips for how to improve your title’s discoverability:
Make the title specific
Place the main concept at the beginning
Only use abbreviations and acronyms if it is common terminology
Avoid phrases such as "effect of," "involvement of," "evidence of"
Instead of "Evidence in X in Y process," try "X impacts Y through Z"
Titles should be concise, specific, and informative. For scientific manuscripts, do not use overly general titles, declarative titles, titles that include the direction of study results, or questions as titles. For reports of clinical trials, meta-analyses, and systematic reviews, include the type of study as a subtitle (e.g., A Randomized Clinical Trial, A Meta-analysis, A Systematic Review). For reports of other types of research, do not include study type or design in the title or subtitle.
Abstract
Abstracts must be 250 words or less, and should be intelligible without reference to the main manuscript text. Abstracts must be organized into four sections: Background, Methods, Results and Conclusions. The purpose and rationale of the study should be included in the Background section and sample sizes must be included in Methods section.
References
References should be numbered consecutively according to the order in which they are cited in the text. A reference cited only in a table or figure is numbered within the sequence established by the first mention of that table or figure in the text. References must include the most recent related work published in the field of study. Please be sure to perform a current search of the literature to ensure inclusion of the most recent publications. Use of references more than 10 years old is discouraged unless they are classic or unique works. Authors must verify all references. The reference list should follow the text of the manuscript. Follow the AMA Manual of Style (10th ed.) for reference formatting and punctuation.
In the reference list, abbreviate names of journals according to MEDLINE/Index Medicus. For five or more authors, list the first three names followed by "et al." Please note the following examples for format and punctuation:
Journal
1. Patel Z, Thamboo A, Rudmik L, et al. Surgical Therapy versus Continued Medical Therapy for Medically Refractory Chronic Rhinosinusitis: A Systematic Review and Meta-Analysis. Intl. Forum of Allergy & Rhinology 2016;7(2):119-127.
Book
2. Kay AB, Kaplan AP, Bousquet J, et al. Allergy and Allergic Diseases. 2nd ed. Hoboken, NJ: Wiley-Blackwell; 2009.
Chapter in a book
3. Corrigan C. T Cells and Cytokines in Asthma and Allergic Inflammation. In: Kay AB, Kaplan AP, Bousquet J, et al., eds. Allergy and Allergic Diseases. 2nd ed. Hoboken, NJ: Wiley-Blackwell; 2009:48-82.
Web site
4. Health on the Net Foundation. Health on the Net Foundation code of conduct (HONcode) for medical and health Web sites. Available at: http://www.hon.ch/HONcode/Conduct.html. Accessed August 26, 2008.
Tables
Tables must be created using the table tool in Word. Each table must be included on a separate page at the end of the main manuscript document and be accompanied by a table legend. Number the tables consecutively in the order in which they are cited in the text (e.g., Table 1, Table 2, etc.). Include a brief descriptive title for each table. Do not use bulleted lists in tables. Do not embed tables in the manuscript text.
Figures and Illustrations
*Authors are encouraged to submit their figure files in color. There is no charge associated with color figures.* Number figures consecutively according to the order in which they are cited in the text. The figures should immediately follow the tables in the manuscript and should be accompanied by a figure legend. Each file must contain a single figure and be named by figure # (e.g., Figure 1, Figure 2, etc.). Files containing individual panels will not be accepted. Figures must be in TIFF, EPS, or JPG format. Do not embed figures in the manuscript text.
Figures (line art): Electronic Formatting:
Each figure should be aved and uploaded in a separate file
Figure text/labeling should be in at least 9 point Arial font, to ensure readability in print
All figures submitted electronically must be saved as TIFF, EPS, or JPG files
The following resolutions are required to ensure print quality: 1200 dpi for line art; 300 dpi for halftones/color (CMYK); 600 dpi for combination halftones/color
The submission of figures that do not conform to journal requirements will cause a delay in publication. International Forum of Allergy & Rhinology reserves the right to resize and/or crop photographs to fit the Journal’s format where appropriate.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/20426984/homepage/forauthors.html
